Foundation Medicine, Inc. recalls
7 notices naming Foundation Medicine, Inc. as the recalling firm, since May 21, 2025. A notice covers specific products and lots, not every product of the firm.
Hazard and remedy text is quoted from the agency, unedited. The tag names the kind of risk with a word from that text. Every notice links to its official page.
Foundation Medicine, Inc.: Hamilton Microlab STAR Liquid Handler
Hazard (FDA): Software issue that can cause an increase in spontaneous software closures.
FDAMedical devices
Foundation Medicine, Inc.: Protocol Configuration Tool
Hazard (FDA): Potential for spontaneous closures of Hamilton HxRunControl software during execution of Autolys protocols after deployment of the PCT software for AutoLys Hamilton STAR.
FDAMedical devices
Foundation Medicine, Inc.: Sequencing Agent SEQ0067
Hazard (FDA): Possible increase in phasing, potentially resulting in false-positive BARD1 splice site indel artifact variants
FDAMedical devices
Foundation Medicine, Inc.: FoundationOne CDx and 1 more
Hazard (FDA): Reports were sent to customers without the companion diagnostic (CDx) Claims Page. Claims pages were distributed via amended reports within 7 days of the issue occurrence.
FDAMedical devices
Foundation Medicine, Inc.: FoundationOne Companion Diagnostic
Hazard (FDA): An incorrect negative claim was identified on the claims page; the device variant information was displayed correctly in the tumor profiling section of the FDA-approved test report.
FDAMedical devices
Foundation Medicine, Inc.: FoundationOne Companion Diagnostic
Hazard (FDA): Two (2) reports were sent to customers with an incorrect negative claim on the claims page; the device variant information was displayed correctly in the tumor profiling section of both FDA-approved test reports.
FDAMedical devices
Foundation Medicine, Inc.: FoundationOne Companion Diagnostic
Hazard (FDA): Four (4) total reports were sent to customers with clinically relevant variants requiring amendment, one (1) of which with an incorrect negative CDx claim. The remaining three (3) with tumor profiling result changes…
FDAMedical devices